Hapax Pharma Private Limited
About Hapax Pharma Private Limited
Data last updated:
Hapax Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2014PTC080569. Its GSTIN is 24AADCH4653E1ZV (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kartik Nalinbhai Raval and Sanjaykumar Jitendrabhai Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.5 Lakh. For the same year it recorded a net loss of ₹6,348 (net margin -4.2%) and EBITDA of -₹6,348 (EBITDA margin -4.2%). Revenue has declined at a compounded annual rate (CAGR) of 38% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 413 – 4th Flr Shanti Arcade Opp. Pushpak Appt Nr. Akash – 3 132 Ring Road Naranp, Ura, Ahmedabad, Gujarat, India – 380014
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Hapax Pharma Private Limited FY 2025 filings available
Hapax Pharma Private Limited reported revenue of ₹1.5 Lakh for FY 2023.
Compounded Annual Growth Rate (CAGR) of Hapax Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 38% over five years. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hapax Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹6,348 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6,348 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hapax Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hapax Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hapax Pharma Private Limited
Hapax Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Its own revenue is ₹1.5 Lakh.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catex Pharama Private Limited | ₹1.52 Lakh | ₹11.23 Lakh | -738% | Gandhinagar, Gujarat, India | ||
| Genesen Labs Limited | ₹1.52 Lakh | ₹1.18 Lakh | 78% | -32% | Mumbai, Maharashtra, India | |
| Nutrinova Healthcare Private Limited | ₹1.51 Lakh | ₹79,692 | 53% | Kanpur, Uttar Pradesh, India | ||
| Avensis Exim Private Limited | ₹1.5 Lakh | ₹22,959 | 15% | -87% | Ahmedabad, Gujarat, India | |
| Sweta Pharma Pvt Ltd | ₹1.5 Lakh | ₹11.78 Lakh | -785% | -65% | Mumbai, Maharashtra, India | |
| Hapax Pharma Private Limited this company | ₹1.5 Lakh | ₹6,348 | -4.2% | Ahmedabad, Gujarat, India | ||
| BKNB Trading Private Limited | ₹1.46 Lakh | ₹1.23 Lakh | 84% | +254% | Delhi, India | |
| Saikam Pharmaceutical Private Limited | ₹1.46 Lakh | ₹16,256 | -11% | +704% | Dehradun, Uttarakhand, India | |
| Quickdist Private Limited | ₹1.46 Lakh | ₹3.58 Lakh | -246% | Mulshi, Maharashtra, India | ||
| Bonna-Agela India Private Limited | ₹1.44 Lakh | ₹17.64 Lakh | -1224% | +242% | Delhi, India | |
| Ishwer Ocean Herbal Company Private Limited | ₹1.42 Lakh | ₹24,645 | -17% | -76% | Panipat, Haryana, India |
Peers are the five companies nearest above and the five nearest below Hapax Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.
Auditor Details of Hapax Pharma Private Limited
Hapax Pharma Private Limited is audited by ASHVIN K YAGNIK & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHVIN K YAGNIK & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Hapax Pharma Private Limited
Hapax Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartik Nalinbhai Raval Also directs: Cuidado Medico Private Limited | Director | 25 Aug 2014 | 12 Years 1 Months | Current |
| Sanjaykumar Jitendrabhai Jha Also directs: Injexa Lifesciences Private Limited, Santis Pharmaceuticals Private Limited, Cuidado Medico Private Limited and 5 more | Director | 25 Aug 2014 | 12 Years 1 Months | Current |
| Prakash Ambalal Patel Also directs: Dhwanit Consultancy LLP, Kesar Finechem Private Limited, Kesar Pharma Limited and 2 more | Director | 02 Feb 2019 | 7 Years 8 Months | Current |
| Kalpesh Navnitlal Shah Also directs: Kesar Finechem Private Limited, Kesar Pharma Limited | Director | 02 Feb 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Hapax Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hapax Pharma Private Limited
Hapax Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hapax Pharma Private Limited
Employment history and EPFO contributions of people linked to Hapax Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hapax Pharma Private Limited
Hapax Pharma Private Limited has 8 board changes on record since 2014: 4 appointments and 4 cessations. The latest: Kalpesh Navnitlal Shah ceased to be Additional Director on 30 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Hapax Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hapax Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hapax Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hapax Pharma Private Limited
Hapax Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCH4653E1ZV | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hapax Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hapax Pharma Private Limited
Hapax Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 August 2014 (12+ years old) and is registered under CIN U24232GJ2014PTC080569.
Hapax Pharma reported revenue of ₹1.5 Lakh for FY 2023.
Hapax Pharma has 4 current directors:
- Kartik Nalinbhai Raval - Director
- Sanjaykumar Jitendrabhai Jha - Director
- Prakash Ambalal Patel - Director
- Kalpesh Navnitlal Shah - Director
Hapax Pharma reported a net loss of ₹6,348 (net margin -4.2%) and EBITDA of -₹6,348 (EBITDA margin -4.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hapax Pharma is -38% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hapax Pharma is 24AADCH4653E1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Hapax Pharma is U24232GJ2014PTC080569. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hapax Pharma was incorporated on 25 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Hapax Pharma by revenue are Catex Pharama Private Limited, Genesen Labs Limited, Nutrinova Healthcare Private Limited, Avensis Exim Private Limited, Sweta Pharma Pvt Ltd and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Kalpesh Navnitlal Shah ceased to be Additional Director on 30 Sep 2019. Prakash Ambalal Patel ceased to be Additional Director on 30 Sep 2019. Ambalal Chimanlal Patel ceased to be Director on 02 Feb 2019. Hapax Pharma has 8 board changes on record in total.
The registered office of Hapax Pharma is at Shop No. 413 – 4th Flr Shanti Arcade Opp. Pushpak Appt Nr. Akash – 3 132 Ring Road Naranp, Ura, Ahmedabad, Gujarat, India – 380014.